Promoting Equitable and Affordable Patient Access to Safe and Effective Innovations in Donation and Transplantation of Substances of Human Origin and Derived Therapies
Natividad Cuende(Junta de Andalucía), Gabriel C. Oniscu(Edinburgh Royal Infirmary), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Beatriz Domínguez‐Gil(Universidad de Zaragoza), Mickey Koh(St George's Hospital), Börje Haraldsson(University of Gothenburg), Rafael Correa‐Rocha(Hospital General Universitario Gregorio Marañón), Stefan G. Tullius(Brigham and Women's Hospital), Wayne J. Hawthorne(The University of Sydney), Renske M.T. ten Ham(Leidsche Rijn Julius Health Centers), Robert J. Porte(Erasmus MC), Ander Izeta(Biogipuzkoa Health Research Institute), Rachele Ciccocioppo(University of Pavia), Nancy L. Ascher(University of California, San Francisco), Vincenzo De Angelis(World Health Organization Regional Office for South-East Asia), Martin Börgel(Deutsche Gesellschaft für Muskelkranke), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Giuseppe Orlando(Wake Forest University), Verena Plattner(Federal Ministry of Social Affairs, Health, Care and Consumer Protection), Gabriel Gondolesi(Miller Orthopedic Specialist)
Cited by 12
Related Papers
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538